1. Home
  2. EVH vs IMRX Comparison

EVH vs IMRX Comparison

Compare EVH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

N/A

Current Price

$3.03

Market Cap

344.8M

ML Signal

N/A

Logo Immuneering Corporation

IMRX

Immuneering Corporation

N/A

Current Price

$5.41

Market Cap

322.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVH
IMRX
Founded
2011
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.8M
322.8M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
EVH
IMRX
Price
$3.03
$5.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
5
Target Price
$7.93
$17.20
AVG Volume (30 Days)
3.1M
601.3K
Earning Date
05-20-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
$907,957,000.00
N/A
Revenue This Year
$33.03
N/A
Revenue Next Year
$16.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$1.10
52 Week High
$11.92
$10.08

Technical Indicators

Market Signals
Indicator
EVH
IMRX
Relative Strength Index (RSI) 45.28 54.25
Support Level $2.53 $5.34
Resistance Level $4.20 $5.55
Average True Range (ATR) 0.27 0.27
MACD 0.01 0.07
Stochastic Oscillator 43.10 60.48

Price Performance

Historical Comparison
EVH
IMRX

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: